| Financial Year |
March 31 2023 |
| Monetary Funds |
955,311,116.65 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
310,000.00 |
| Accounts Receivable |
1,929,348,512.64 |
| Advances to Suppliers |
26,210,214.71 |
| Other Receivables |
96,040,639.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,146,647.69 |
| Other Current Assets |
4,603,597.91 |
| Total Current Assets |
3,026,970,728.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,892,697.45 |
| Long-term Equity Investment |
136,433,606.09 |
| Investment Properties |
-- |
| Fixed Assetes |
10,285,997.06 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
232,970,793.67 |
| R&D expenses |
20,175,226.52 |
| Goodwill |
138,451,755.42 |
| Long-Term Deferred and Prepaid Expenses |
17,616,745.43 |
| Deferred Income Tax Assets |
33,646,390.35 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
708,578,905.13 |
| Total Assets |
3,735,549,634.10 |
| Short-Term Loans |
44,675,778.72 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
131,968,344.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
556,134,225.57 |
| Taxes Payable |
175,197,628.70 |
| Interest Payable |
-- |
| Dividend Payable |
14,801,446.37 |
| Other payables |
162,647,028.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
48,895,326.32 |
| Other Current Liabilities |
8,160,986.32 |
| Sub-Total of Current Liabilities |
1,182,581,781.62 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,514,705.44 |
| Deferred Income Tax Liabilities |
43,299,993.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
104,551,852.32 |
| Total Liabilities |
1,287,133,633.94 |
| Paid-In Capital(Or Share Stock) |
196,806,359.00 |
| Capital Surplus |
963,637,240.19 |
| Surplus Reserve |
70,636,168.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,052,155,142.18 |
| Minority Stockholder's Interest |
161,824,544.66 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,286,591,455.50 |
| Owner's Equity（Stockholder's Equity） |
2,448,416,000.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,735,549,634.10 |
